0 9 September 2025 false false false false false false false false false false true false false false false false false No description of principal activity 2024-01-01 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 09659253 2024-01-01 2024-12-31 09659253 2024-12-31 09659253 2023-12-31 09659253 2023-01-01 2023-12-31 09659253 2023-12-31 09659253 2022-12-31 09659253 bus:Director2 2024-01-01 2024-12-31 09659253 core:WithinOneYear 2024-12-31 09659253 core:WithinOneYear 2023-12-31 09659253 core:ShareCapital 2024-12-31 09659253 core:ShareCapital 2023-12-31 09659253 core:RetainedEarningsAccumulatedLosses 2024-12-31 09659253 core:RetainedEarningsAccumulatedLosses 2023-12-31 09659253 bus:Director1 2024-01-01 2024-12-31 09659253 bus:SmallEntities 2024-01-01 2024-12-31 09659253 bus:Audited 2024-01-01 2024-12-31 09659253 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 09659253 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 09659253 bus:FullAccounts 2024-01-01 2024-12-31
COMPANY REGISTRATION NUMBER: 09659253
Abbey Healthcare (Management Services) Limited
Filleted Financial Statements
For the year ended
31 December 2024
Abbey Healthcare (Management Services) Limited
Statement of Financial Position
31 December 2024
2024
2023
Note
£
£
Current assets
Debtors
4
188,818
188,818
Creditors: amounts falling due within one year
5
187,465
187,431
---------
---------
Net current assets
1,353
1,387
-------
-------
Total assets less current liabilities
1,353
1,387
-------
-------
Capital and reserves
Called up share capital
1
1
Profit and loss account
1,352
1,386
-------
-------
Shareholders funds
1,353
1,387
-------
-------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements were approved by the board of directors and authorised for issue on 8 September 2025 , and are signed on behalf of the board by:
A Taylor
Director
Company registration number: 09659253
Abbey Healthcare (Management Services) Limited
Notes to the Financial Statements
Year ended 31 December 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Abbey Healthcare, Sutherland House, 70-78 West Hendon Broadway, London, NW9 7BT.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis.
Going concern
The company has made a loss during the year and is in a net asset position on year end. It has received group support and accordingly the financial statements have been prepared on a going concern basis. The directors are confident that group has the ability to meet its financial obligations as they fall due for a period of at least 12 months from the date of approval of the financial statements.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Apart from the accounting policies disclosed there were no other key sources of estimation uncertainty.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax.
Financial instruments
The company holds basic financial instruments as defined in FRS102. The financial assets and financial liabilities of the company and their measurement basis are as follows: Financial assets - trade and other debtors are basic financial instruments and are debt instruments measured at amortised cost. Prepayments are not financial instruments. Cash at bank is classified as a basic financial instrument and is measured at amortised cost. Financial liabilities - trade creditors, accruals and other creditors are financial instruments, and are measured at amortised cost. Taxation and social security are not included in the financial instruments disclosure definition.
4. Debtors
2024
2023
£
£
Amounts owed by group undertakings and undertakings in which the company has a participating interest
181,468
181,468
Other debtors
7,350
7,350
---------
---------
188,818
188,818
---------
---------
5. Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
2
2
Amounts owed to group undertakings and undertakings in which the company has a participating interest
187,463
187,429
---------
---------
187,465
187,431
---------
---------
6. Summary audit opinion
The auditor's report dated 9 September 2025 was unqualified .
The senior statutory auditor was Jonathan Day , for and on behalf of Streets Audit LLP .
7. Controlling party
The company was under the control of the Trustees of the Prabhdyal Sodhi Overseas Settlement throughout the year, an entity based in Gibraltar. The immediate parent company is Lansbury Limited , a company incorporated in Gibraltar.